RUNX2 and cleidocranial dysplasia 1: The authors used CAGE-seq to perform total transcriptional profiling of induced pluripotent stem (iPS) cells (CCDiPS) derived from patients with cleidocranial dysplasia (CCD) with a genetic mutation in RUNX2 after osteoblast induction.